1Y Annualised Return
▲27.44%
3Y Annualised Return
▲28.55%
5Y Annualised Return
▲2.58%
10Y Annualised Return
▲0.09%
|
|
|
Over the past
Market Cap (in crs)
1,598.25
Face Value
1
Turnover (in lacs)
257.94
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
207.47 Cr | 197.99 Cr | 210.42 Cr | 217.68 Cr | 183.64 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
846.22 Cr | 798.98 Cr | 769.37 Cr | 778.95 Cr | 597.43 Cr | 728.49 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
44.36 Cr | 16.65 Cr | 25.8 Cr | 25.69 Cr | 22.11 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
90.26 Cr | 81.58 Cr | 76.73 Cr | 23.13 Cr | 73.97 Cr | 95.25 Cr |
Bliss GVS Pharma Ltd reported a 19.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 29.4%.
Its expenses for the quarter were up by 0.7% QoQ and 14.0% YoY.
The net profit decreased 1001.6% QoQ and increased 100.6% YoY.
The earnings per share (EPS) of Bliss GVS Pharma Ltd stood at 4 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 86139 Rs | 189646 Rs |
Week Rs | 126538 Rs | 257847 Rs |
Month Rs | 232018 Rs | 625977 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
248.23 | 1,653.99 | 153.1 | 328.04 | 250.10 | 4.50% | 1.28% | 21.11% | 51.40% | 62.11% | 1.01% | 38.68 | 0.00 | 6.88 | |
124.78 | 1,148.48 | 98 | 317 | 131.55 | 24.93% | 23.06% | -15.13% | -55.37% | 25.91% | 0.40% | 0.00 | 0.00 | 3.99 | |
18.08 | 1,699.52 | 14.1 | 26.29 | 17.83 | 5.24% | 4.09% | 16.05% | -27.42% | 0.00% | 0.00% | 29.61 | 0.00 | 4.99 | |
29.46 | 1,289.99 | 5.75 | 29.46 | 28.89 | 10.30% | 64.12% | 19.85% | 362.48% | 2,679.25% | 0.03% | 128.09 | 0.00 | 20.53 | |
435.80 | 1,376.40 | 333.8 | 745 | 425.65 | 2.10% | -3.61% | -31.06% | 13.73% | 17.86% | 0.23% | 29.25 | 0.00 | 3.07 | |
43.95 | 1,679.40 | 30.51 | 60.5 | 43.86 | 39.92% | 43.30% | 19.27% | -21.56% | 51.40% | 0.23% | 27.66 | 0.00 | 2.98 |
Bliss GVS Pharma share price is ₹151.39 in NSE and ₹151.5 in BSE as on 16/9/2025.
Bliss GVS Pharma share price in the past 1-year return was 12.85. The Bliss GVS Pharma share hit a 1-year low of Rs. 106.04 and a 1-year high of Rs. 190.97.
The market cap of Bliss GVS Pharma is Rs. 1598.25 Cr. as of 16/9/2025.
The PE ratios of Bliss GVS Pharma is 22.65 as of 16/9/2025.
The PB ratios of Bliss GVS Pharma is 1.51 as of 16/9/2025
You can easily buy Bliss GVS Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Bliss GVS Pharma share price is ₹190.97 and ₹106.04 as of 16/9/2025.
The earnings per share (EPS) of Bliss GVS Pharma stood at 4 during Q1 FY 2025-26.
Please be aware that Bliss GVS Pharma stock prices are subject to continuous fluctuations due to various factors.